These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 21449994
1. Relationship between acute improvement in left ventricular function to 6-month outcomes after cardiac resynchronization therapy in patients with chronic heart failure. Pires LA, Ghio S, Chung ES, Tavazzi L, Abraham WT, Gerritse B. Congest Heart Fail; 2011; 17(2):65-70. PubMed ID: 21449994 [Abstract] [Full Text] [Related]
2. Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy. Hsing JM, Selzman KA, Leclercq C, Pires LA, McLaughlin MG, McRae SE, Peterson BJ, Zimetbaum PJ. Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):851-7. PubMed ID: 21956038 [Abstract] [Full Text] [Related]
3. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial. Pouleur AC, Knappe D, Shah AM, Uno H, Bourgoun M, Foster E, McNitt S, Hall WJ, Zareba W, Goldenberg I, Moss AJ, Pfeffer MA, Solomon SD, MADIT-CRT Investigators. Eur Heart J; 2011 Jul; 32(14):1720-9. PubMed ID: 21609974 [Abstract] [Full Text] [Related]
4. Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT. Knappe D, Pouleur AC, Shah AM, Bourgoun M, Brown MW, Foster E, Pfeffer MA, Moss AJ, Solomon SD, MADIT-CRT Investigators. J Card Fail; 2013 Mar; 19(3):149-55. PubMed ID: 23482074 [Abstract] [Full Text] [Related]
5. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure. Porciani MC, Macioce R, Demarchi G, Chiostri M, Musilli N, Cappelli F, Lilli A, Ricciardi G, Padeletti L. Eur J Echocardiogr; 2006 Jan; 7(1):31-9. PubMed ID: 16378918 [Abstract] [Full Text] [Related]
6. Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure. Zhang Q, Fung JW, Auricchio A, Chan JY, Kum LC, Wu LW, Yu CM. Eur Heart J; 2006 Jun; 27(12):1423-30. PubMed ID: 16682380 [Abstract] [Full Text] [Related]
7. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure. Mollema SA, Bleeker GB, van der Wall EE, Schalij MJ, Bax JJ. Am J Cardiol; 2007 Dec 01; 100(11):1665-70. PubMed ID: 18036366 [Abstract] [Full Text] [Related]
8. Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy. Ypenburg C, Sieders A, Bleeker GB, Holman ER, van der Wall EE, Schalij MJ, Bax JJ. Am Heart J; 2007 Dec 01; 154(6):1160-5. PubMed ID: 18035090 [Abstract] [Full Text] [Related]
9. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure. Linde C, Daubert C, Abraham WT, St John Sutton M, Ghio S, Hassager C, Herre JM, Bergemann TL, Gold MR, REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group. Circ Heart Fail; 2013 Nov 01; 6(6):1180-9. PubMed ID: 24014828 [Abstract] [Full Text] [Related]
10. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. Hsu JC, Solomon SD, Bourgoun M, McNitt S, Goldenberg I, Klein H, Moss AJ, Foster E, MADIT-CRT Executive Committee. J Am Coll Cardiol; 2012 Jun 19; 59(25):2366-73. PubMed ID: 22698490 [Abstract] [Full Text] [Related]
11. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C, REVERSE Study Group. J Am Coll Cardiol; 2009 Nov 10; 54(20):1837-46. PubMed ID: 19800193 [Abstract] [Full Text] [Related]
12. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. Ypenburg C, van Bommel RJ, Borleffs CJ, Bleeker GB, Boersma E, Schalij MJ, Bax JJ. J Am Coll Cardiol; 2009 Feb 10; 53(6):483-90. PubMed ID: 19195605 [Abstract] [Full Text] [Related]
13. Effect of cardiac resynchronization therapy on subendo- and subepicardial left ventricular twist mechanics and relation to favorable outcome. Bertini M, Delgado V, Nucifora G, Marsan NA, Ng AC, Shanks M, Van Bommel RJ, Borleffs CJ, Ewe SH, Boriani G, Biffi M, Schalij MJ, Bax JJ. Am J Cardiol; 2010 Sep 01; 106(5):682-7. PubMed ID: 20723646 [Abstract] [Full Text] [Related]
14. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. J Am Coll Cardiol; 2004 Nov 02; 44(9):1834-40. PubMed ID: 15519016 [Abstract] [Full Text] [Related]
15. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure. Bonanno C, Ometto R, Pasinato S, Finocchi G, La Vecchia L, Fontanelli A. Ital Heart J; 2004 May 02; 5(5):364-70. PubMed ID: 15185900 [Abstract] [Full Text] [Related]
16. Impact of reduction in early- and late-systolic functional mitral regurgitation on reverse remodelling after cardiac resynchronization therapy. Liang YJ, Zhang Q, Fung JW, Chan JY, Yip GW, Lam YY, Yu CM. Eur Heart J; 2010 Oct 02; 31(19):2359-68. PubMed ID: 20501482 [Abstract] [Full Text] [Related]
17. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure. Mangiavacchi M, Gasparini M, Faletra F, Klersy C, Morenghi E, Galimberti P, Genovese L, Regoli F, De Chiara F, Bragato R, Andreuzzi B, Pini D, Gronda E. Am Heart J; 2006 Feb 02; 151(2):477.e1-477.e6. PubMed ID: 16442917 [Abstract] [Full Text] [Related]
18. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E. Circulation; 2006 Jan 17; 113(2):266-72. PubMed ID: 16401777 [Abstract] [Full Text] [Related]
19. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors. Gasparini M, Regoli F, Ceriotti C, Galimberti P, Bragato R, De Vita S, Pini D, Andreuzzi B, Mangiavacchi M, Klersy C. Am Heart J; 2008 Mar 17; 155(3):507-14. PubMed ID: 18294488 [Abstract] [Full Text] [Related]
20. Predicting hyperresponse among pacemaker-dependent nonischemic cardiomyopathy patients upgraded to cardiac resynchronization. Adelstein E, Schwartzman D, Gorcsan J, Saba S. J Cardiovasc Electrophysiol; 2011 Aug 17; 22(8):905-11. PubMed ID: 21332868 [Abstract] [Full Text] [Related] Page: [Next] [New Search]